Theragen Etex Financials
| 066700 Stock | KRW 3,135 125.00 4.15% |
Theragen |
Understanding current and past Theragen Etex Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Theragen Etex's financial statements are interrelated, with each one affecting the others. For example, an increase in Theragen Etex's assets may result in an increase in income on the income statement.
Please note, the presentation of Theragen Etex's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Theragen Etex's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Theragen Etex's management manipulating its earnings.
Theragen Etex Stock Summary
Theragen Etex competes with Tae Kyung, Sung Bo, Chin Yang, Samlip General, and Daehan Synthetic. ,Ltd., together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical products. ,Ltd. was founded in 1987 and is headquartered in Seoul, South Korea. THERAGEN ETEX is traded on Korean Securities Dealers Automated Quotations in South Korea.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR7066700006 |
| Business Address | Daegwan Building, Seoul, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.theragenetex.com |
| Phone | 82 2 3463 1110 |
| Currency | KRW - South Korean Won |
You should never invest in Theragen Etex without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Theragen Stock, because this is throwing your money away. Analyzing the key information contained in Theragen Etex's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Theragen Etex Key Financial Ratios
Theragen Etex's financial ratios allow both analysts and investors to convert raw data from Theragen Etex's financial statements into concise, actionable information that can be used to evaluate the performance of Theragen Etex over time and compare it to other companies across industries.| Return On Equity | 3.46 | |||
| Return On Asset | -0.0115 | |||
| Number Of Employees | 164 | |||
| Beta | 0.99 | |||
| Z Score | 1.8 |
Theragen Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Theragen Etex's current stock value. Our valuation model uses many indicators to compare Theragen Etex value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Theragen Etex competition to find correlations between indicators driving Theragen Etex's intrinsic value. More Info.Theragen Etex CoLtd is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Theragen Etex by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Theragen Etex's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Theragen Etex CoLtd Systematic Risk
Theragen Etex's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Theragen Etex volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Theragen Etex CoLtd correlated with the market. If Beta is less than 0 Theragen Etex generally moves in the opposite direction as compared to the market. If Theragen Etex Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Theragen Etex CoLtd is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Theragen Etex is generally in the same direction as the market. If Beta > 1 Theragen Etex moves generally in the same direction as, but more than the movement of the benchmark.
Theragen Etex December 11, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Theragen Etex help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Theragen Etex CoLtd. We use our internally-developed statistical techniques to arrive at the intrinsic value of Theragen Etex CoLtd based on widely used predictive technical indicators. In general, we focus on analyzing Theragen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Theragen Etex's daily price indicators and compare them against related drivers.
| Information Ratio | (0.21) | |||
| Maximum Drawdown | 10.97 | |||
| Value At Risk | (4.03) | |||
| Potential Upside | 2.5 |
Complementary Tools for Theragen Stock analysis
When running Theragen Etex's price analysis, check to measure Theragen Etex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theragen Etex is operating at the current time. Most of Theragen Etex's value examination focuses on studying past and present price action to predict the probability of Theragen Etex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theragen Etex's price. Additionally, you may evaluate how the addition of Theragen Etex to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |